Business Context and Reporting Period
Company: TherapeuticsMD, Inc. (Nasdaq: TXMD)
Filing Type: Form 8-K (Current Report)
Date of Report: May 13, 2020
Event: Regulation FD Disclosure (Item 7.01) regarding an investor presentation furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an investor presentation that may contain such information, but the presentation itself is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated May 13, 2020, for use in meetings with investors or analysts.
Legal Disclaimer: The information in this report and the accompanying exhibit is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the investor presentation) for specific financial data, guidance, and operational updates not included in this 8-K summary.
- Verify the trading status of Common Stock (TXMD) on The Nasdaq Stock Market LLC.
- Confirm the company's status as a Nevada corporation with IRS EIN 87-0233535.
- Note that the filing explicitly disclaims the "filed" status of the presentation content for liability purposes.